awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38409615-CDAD1019-2184-40FE-8137-08DA0C34DF98
Q38409615-CDAD1019-2184-40FE-8137-08DA0C34DF98
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38409615-CDAD1019-2184-40FE-8137-08DA0C34DF98
Additive antiangiogenesis effect of ginsenoside Rg3 with low-dose metronomic temozolomide on rat glioma cells both in vivo and in vitro.
P2860
Q38409615-CDAD1019-2184-40FE-8137-08DA0C34DF98
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38409615-CDAD1019-2184-40FE-8137-08DA0C34DF98
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9e207f73ef7861c622b15f62de46994f89c625fb
P2860
Phase II trial of low-dose continuous (metronomic) treatment of temozolomide for recurrent glioblastoma.